Publication | Open Access
Association between sodium–glucose co-transporter 2 inhibitors and risk of psoriasis in patients with diabetes mellitus: a nationwide population-based cohort study
11
Citations
24
References
2022
Year
SGLT2i-mediated protective effects in psoriasis could not be established. SGLT2i treatment increased psoriasis risk by 2.7-fold in patients with T2DM exhibiting renal diseases.
| Year | Citations | |
|---|---|---|
Page 1
Page 1